speb/financial-data huggingface dataset:
CRS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 122500000.00
CRS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 122500000.00
CRS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 122500000.00
CRS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 122500000.00
CRS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 122500000.00
CRS income_statement (quarterly, 2025-09-30) — Net Interest Income: -10700000.00
CRS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -10700000.00
CRS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -45500000.00
CRS balance_sheet (quarterly, 2025-09-30) — Net PPE: 1372900000.00
CRS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -42600000.00
CRS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1675800000.00
CRS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 8000000.00
CRS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 169000000.00
CRS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 8000000.00
CRS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 169000000.00
CRS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 154800000.00
CRS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 191500000.00
CRS income_statement (quarterly, 2025-09-30) — Normalized Income: 120638800.00
CRS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 39200000.00
CRS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 3900000.00
CRS income_statement (quarterly, 2025-09-30) — Operating Income: 153300000.00
CRS income_statement (quarterly, 2025-09-30) — Operating Revenue: 733700000.00
CRS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 49743177.00
CRS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 72100000.00
CRS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1800000.00
CRS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -67700000.00
CRS income_statement (quarterly, 2025-09-30) — Other Income Expense: 2200000.00
CRS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 8100000.00
CRS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 113700000.00
CRS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 94600000.00
CRS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
CRS balance_sheet (quarterly, 2025-09-30) — Payables: 254700000.00
CRS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 272400000.00
CRS cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: 3600000.00
CRS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 86500000.00
CRS income_statement (quarterly, 2025-09-30) — Pretax Income: 144800000.00
CRS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 500000.00
CRS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -42600000.00
CRS balance_sheet (quarterly, 2025-09-30) — Raw Materials: 191700000.00
CRS balance_sheet (quarterly, 2025-09-30) — Receivables: 613600000.00
CRS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 517300000.00
CRS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 36000000.00
CRS cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -49100000.00
CRS income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
CRS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1822600000.00
CRS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 63100000.00
CRS balance_sheet (quarterly, 2025-09-30) — Share Issued: 57243135.00
CRS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CRS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5600000.00
CRS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1911200000.00
CRS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1675800000.00
CRS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 338800.00
CRS income_statement (quarterly, 2025-09-30) — Tax Provision: 22300000.00
CRS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
CRS balance_sheet (quarterly, 2025-09-30) — Total Assets: 3402200000.00
CRS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2606900000.00
CRS balance_sheet (quarterly, 2025-09-30) — Total Debt: 704200000.00
CRS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1911200000.00
CRS income_statement (quarterly, 2025-09-30) — Total Expenses: 580400000.00
CRS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1491000000.00
CRS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1730000000.00
CRS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1114100000.00
CRS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 153300000.00
CRS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 8400000.00
CRS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 2200000.00
CRS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 2200000.00
CRS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 7499958.00
CRS balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 468600000.00
CRS balance_sheet (quarterly, 2025-09-30) — Work In Process: 450400000.00
CRS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1295300000.00
CRS income_statement (quarterly, 2025-12-31) — +Operating Expense: 63100000.00
CRS income_statement (quarterly, 2025-12-31) — +Total Revenue: 728000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 270100000.00
CRS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 603500000.00
CRS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 342600000.00
CRS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 49809340.00
CRS income_statement (quarterly, 2025-12-31) — Basic EPS: 2.11
CRS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 208000000.00
CRS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -46300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 8600000.00
CRS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 286600000.00
CRS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 231900000.00
CRS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 231900000.00
CRS cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -10000000.00
CRS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -62500000.00
CRS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -46300000.00
CRS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 132200000.00
CRS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 13500000.00
CRS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 12700000.00
CRS cash_flow (quarterly, 2025-12-31) — Change In Inventory: -43500000.00
CRS cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -23300000.00
CRS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -7000000.00
CRS cash_flow (quarterly, 2025-12-31) — Change In Payable: 13500000.00
CRS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 26200000.00
CRS cash_flow (quarterly, 2025-12-31) — Change In Receivables: 10200000.00
CRS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -37400000.00
CRS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 10200000.00
CRS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 23400000.00
CRS balance_sheet (quarterly, 2025-12-31) — Common Stock: 286600000.00
CRS cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -10000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1985400000.00
CRS cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -32100000.00
CRS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 509700000.00
CRS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 17500000.00
CRS balance_sheet (quarterly, 2025-12-31) — Current Assets: 1756000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 8600000.00
CRS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 8600000.00
CRS balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 6000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 6000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 412800000.00
CRS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 2900000.00
CRS cash_flow (quarterly, 2025-12-31) — Deferred Tax: 2900000.00
CRS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 36100000.00
CRS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 36100000.00
CRS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 50382775.00
CRS income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.09
CRS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 105200000.00
CRS income_statement (quarterly, 2025-12-31) — EBIT: 141600000.00
CRS income_statement (quarterly, 2025-12-31) — EBITDA: 177700000.00
CRS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 500000.00
CRS balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 150400000.00
CRS cash_flow (quarterly, 2025-12-31) — End Cash Position: 231900000.00
CRS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -62500000.00
CRS balance_sheet (quarterly, 2025-12-31) — Finished Goods: 156400000.00
CRS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 85900000.00
CRS cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 100000.00
CRS income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 100000.00
CRS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -65800000.00
CRS balance_sheet (quarterly, 2025-12-31) — Goodwill: 227300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 234000000.00
CRS income_statement (quarterly, 2025-12-31) — Gross Profit: 218300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 1200000.00
CRS income_statement (quarterly, 2025-12-31) — Interest Expense: 11600000.00
CRS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 11600000.00
CRS income_statement (quarterly, 2025-12-31) — Interest Income: 1900000.00
CRS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1900000.00
CRS balance_sheet (quarterly, 2025-12-31) — Interest Payable: 4500000.00
CRS balance_sheet (quarterly, 2025-12-31) — Inventory: 822300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2675500000.00
CRS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -46300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 690100000.00
CRS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 690100000.00
CRS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -32100000.00
CRS balance_sheet (quarterly, 2025-12-31) — Net Debt: 458200000.00
CRS income_statement (quarterly, 2025-12-31) — Net Income: 105300000.00
CRS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 105200000.00
CRS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 105300000.00
CRS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 105300000.00
CRS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 105300000.00
CRS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 105300000.00
CRS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 105300000.00
CRS income_statement (quarterly, 2025-12-31) — Net Interest Income: -9700000.00
CRS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -9700000.00
CRS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -25200000.00
CRS balance_sheet (quarterly, 2025-12-31) — Net PPE: 1394600000.00
CRS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -46300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1751400000.00
CRS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 8000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 172200000.00
CRS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 8000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 172200000.00
CRS balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 150400000.00
CRS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 193200000.00
CRS income_statement (quarterly, 2025-12-31) — Normalized Income: 117855000.00
CRS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 132200000.00
CRS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 19300000.00
CRS income_statement (quarterly, 2025-12-31) — Operating Income: 155200000.00
CRS income_statement (quarterly, 2025-12-31) — Operating Revenue: 728000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 49809340.00
CRS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 98300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1200000.00
CRS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -65800000.00
CRS income_statement (quarterly, 2025-12-31) — Other Income Expense: -15500000.00
CRS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 6700000.00
CRS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 111700000.00
CRS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 93400000.00
CRS income_statement (quarterly, 2025-12-31) — Other Special Charges: 15600000.00
CRS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 100000.00
CRS balance_sheet (quarterly, 2025-12-31) — Payables: 275000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 292500000.00
CRS cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 3600000.00
CRS balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 104500000.00
CRS income_statement (quarterly, 2025-12-31) — Pretax Income: 130000000.00
CRS cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 12700000.00
CRS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -46300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Raw Materials: 193700000.00
CRS balance_sheet (quarterly, 2025-12-31) — Receivables: 603500000.00
CRS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 509700000.00
CRS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 36100000.00
CRS cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -32100000.00
CRS income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CRS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1917900000.00
CRS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 63100000.00
CRS balance_sheet (quarterly, 2025-12-31) — Share Issued: 57328203.00
CRS income_statement (quarterly, 2025-12-31) — Special Income Charges: -15600000.00
CRS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 6000000.00
CRS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1985400000.00
CRS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1751400000.00
CRS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -2945000.00
CRS income_statement (quarterly, 2025-12-31) — Tax Provision: 24700000.00
CRS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.19
CRS balance_sheet (quarterly, 2025-12-31) — Total Assets: 3504300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2675500000.00
CRS balance_sheet (quarterly, 2025-12-31) — Total Debt: 698700000.00
CRS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1985400000.00
CRS income_statement (quarterly, 2025-12-31) — Total Expenses: 572800000.00
CRS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1518900000.00
CRS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1748300000.00
CRS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1106100000.00
CRS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 155200000.00
CRS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 4900000.00
CRS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -15500000.00
CRS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -15500000.00
CRS balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 7518863.00
CRS balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 495900000.00
CRS balance_sheet (quarterly, 2025-12-31) — Work In Process: 472200000.00
CRS balance_sheet (quarterly, 2025-12-31) — Working Capital: 1343200000.00
CRS income_statement (quarterly, 2026-03-31) — +Operating Expense: 65300000.00
CRS income_statement (quarterly, 2026-03-31) — +Total Revenue: 811500000.00
CRS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 322600000.00
CRS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 682000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 349900000.00
CRS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 50000000.00
CRS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.79
CRS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 231900000.00
CRS cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -68700000.00
CRS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 8900000.00
CRS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 286700000.00
CRS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 294800000.00
CRS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 294800000.00
CRS cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -10100000.00
CRS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -62800000.00
CRS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -68700000.00
CRS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 193500000.00
CRS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 47100000.00
CRS cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 42200000.00
CRS cash_flow (quarterly, 2026-03-31) — Change In Inventory: -17200000.00
CRS cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 17100000.00
CRS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -6000000.00
CRS cash_flow (quarterly, 2026-03-31) — Change In Payable: 47100000.00
CRS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 89300000.00
CRS cash_flow (quarterly, 2026-03-31) — Change In Receivables: -80900000.00
CRS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2300000.00
CRS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -80900000.00
CRS cash_flow (quarterly, 2026-03-31) — Changes In Cash: 62000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Common Stock: 286700000.00
CRS cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -10100000.00
CRS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2067600000.00
CRS cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -52700000.00
CRS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 559700000.00
CRS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 15200000.00
CRS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1897600000.00
CRS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 8900000.00
CRS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 8900000.00
CRS balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 6000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 6000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 508300000.00
CRS cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 4100000.00
CRS cash_flow (quarterly, 2026-03-31) — Deferred Tax: 4100000.00
CRS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 36700000.00
CRS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 36700000.00
CRS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 50300000.00
CRS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.77
CRS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 139500000.00
CRS income_statement (quarterly, 2026-03-31) — EBIT: 186800000.00
CRS income_statement (quarterly, 2026-03-31) — EBITDA: 223500000.00
CRS cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 900000.00
CRS balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 145600000.00
CRS cash_flow (quarterly, 2026-03-31) — End Cash Position: 294800000.00
CRS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -62800000.00
CRS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 168800000.00
CRS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 124800000.00
CRS cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 200000.00
CRS income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -1800000.00
CRS balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -67500000.00
CRS balance_sheet (quarterly, 2026-03-31) — Goodwill: 227300000.00
CRS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 232600000.00
CRS income_statement (quarterly, 2026-03-31) — Gross Profit: 251800000.00
CRS balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 1700000.00
CRS income_statement (quarterly, 2026-03-31) — Interest Expense: 10100000.00
CRS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 10100000.00
CRS income_statement (quarterly, 2026-03-31) — Interest Income: 2000000.00
CRS income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Interest Payable: 3300000.00
CRS balance_sheet (quarterly, 2026-03-31) — Inventory: 839200000.00
CRS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2758000000.00
CRS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -68700000.00
CRS cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
CRS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 690400000.00
CRS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 690400000.00
CRS cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
CRS cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
CRS cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -52700000.00
CRS balance_sheet (quarterly, 2026-03-31) — Net Debt: 395600000.00
CRS income_statement (quarterly, 2026-03-31) — Net Income: 139600000.00
CRS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 139500000.00
CRS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 139600000.00
CRS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 139600000.00
CRS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 139600000.00
CRS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 139600000.00
CRS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 139600000.00
CRS income_statement (quarterly, 2026-03-31) — Net Interest Income: -8100000.00
CRS cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
CRS cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
CRS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -8100000.00
CRS cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -700000.00
CRS balance_sheet (quarterly, 2026-03-31) — Net PPE: 1433300000.00
CRS cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -68700000.00
CRS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1835000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 8000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 176400000.00
CRS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 8000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 176400000.00
CRS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 145600000.00
CRS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 225300000.00
CRS income_statement (quarterly, 2026-03-31) — Normalized Income: 141022000.00
CRS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 193500000.00
CRS cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 3800000.00
CRS income_statement (quarterly, 2026-03-31) — Operating Income: 186500000.00
CRS income_statement (quarterly, 2026-03-31) — Operating Revenue: 811500000.00
CRS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 49685074.00
CRS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 81600000.00
CRS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1400000.00
CRS balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -67500000.00
CRS income_statement (quarterly, 2026-03-31) — Other Income Expense: -1700000.00
CRS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 5300000.00
CRS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 107600000.00
CRS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 90800000.00
CRS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 100000.00
CRS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 100000.00
CRS balance_sheet (quarterly, 2026-03-31) — Payables: 329500000.00
CRS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 344700000.00
CRS cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 3600000.00
CRS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 147300000.00
CRS income_statement (quarterly, 2026-03-31) — Pretax Income: 176700000.00
CRS cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 700000.00
CRS cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -68700000.00
CRS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 182500000.00
CRS balance_sheet (quarterly, 2026-03-31) — Receivables: 682000000.00
CRS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 559700000.00
CRS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 36700000.00
CRS cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
CRS cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -52700000.00
CRS income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 0.00
CRS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2047400000.00
CRS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 65300000.00
CRS balance_sheet (quarterly, 2026-03-31) — Share Issued: 57346813.00
CRS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
CRS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 7000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2067600000.00
CRS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1835000000.00
CRS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -378000.00
CRS income_statement (quarterly, 2026-03-31) — Tax Provision: 37100000.00
CRS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
CRS balance_sheet (quarterly, 2026-03-31) — Total Assets: 3679100000.00
CRS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2758000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Total Debt: 699300000.00
CRS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2067600000.00
CRS income_statement (quarterly, 2026-03-31) — Total Expenses: 625000000.00
CRS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1611500000.00
CRS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1781500000.00
CRS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1103200000.00
CRS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 186500000.00
CRS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 6900000.00
CRS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1800000.00
CRS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1800000.00
CRS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 7661739.00
CRS balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 548900000.00
CRS balance_sheet (quarterly, 2026-03-31) — Work In Process: 487900000.00
CRS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1389300000.00
CRS.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 10527.00
CRS.AX balance_sheet (annual, 2021-06-30) — Current Provisions: 9048.00
CRS.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 11115.00
CRS.AX cash_flow (annual, 2021-06-30) — Net Business Purchase And Sale: 3137.00
CRS.AX cash_flow (annual, 2021-06-30) — Net Investment Purchase And Sale: -35435.00
CRS.AX cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 10527.00
CRS.AX income_statement (annual, 2021-06-30) — Other Income Expense: 10527.00
CRS.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 10527.00
CRS.AX cash_flow (annual, 2021-06-30) — Purchase Of Investment: -35435.00
CRS.AX cash_flow (annual, 2021-06-30) — Sale Of Business: 3137.00
CRS.AX income_statement (annual, 2022-06-30) — +Operating Expense: 1361465.00
CRS.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 53959.00
CRS.AX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -41944.00
CRS.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 91451826.00
CRS.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.01
CRS.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 3315439.00
CRS.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -2264181.00
CRS.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -1982831.00
CRS.AX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 74740.00
CRS.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 16487929.00
CRS.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 1958751.00
CRS.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 1958751.00
CRS.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 1958751.00
CRS.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 1831873.00
CRS.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -2264181.00
CRS.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -924380.00
CRS.AX cash_flow (annual, 2022-06-30) — Changes In Cash: -1356688.00
CRS.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -920068.00
CRS.AX balance_sheet (annual, 2022-06-30) — Common Stock: 16487929.00
CRS.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 13276399.00
CRS.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 2000000.00
CRS.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -136125.00
CRS.AX balance_sheet (annual, 2022-06-30) — Current Assets: 2072873.00
CRS.AX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 35471.00
CRS.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 35471.00
CRS.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 302486.00
CRS.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 34299.00
CRS.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 39291.00
CRS.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 39291.00
CRS.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 39291.00
CRS.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 91451826.00
CRS.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.01
CRS.AX income_statement (annual, 2022-06-30) — EBIT: -1360413.00
CRS.AX income_statement (annual, 2022-06-30) — EBITDA: -1321122.00
CRS.AX cash_flow (annual, 2022-06-30) — End Cash Position: 1958751.00
CRS.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 1831873.00
CRS.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -3188561.00
CRS.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 1885275.00
CRS.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 1047241.00
CRS.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 11587225.00
CRS.AX income_statement (annual, 2022-06-30) — Interest Expense: 5639.00
CRS.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 5639.00
CRS.AX income_statement (annual, 2022-06-30) — Interest Income: 1327.00
CRS.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 1327.00
CRS.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -5639.00
CRS.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 5639.00
CRS.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 1327.00
CRS.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 13276399.00
CRS.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -2264181.00
CRS.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 2000000.00
CRS.AX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 39269.00
CRS.AX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 39269.00
CRS.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 11115.00
CRS.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 1863875.00
CRS.AX income_statement (annual, 2022-06-30) — Net Income: -1366052.00
CRS.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -1366052.00
CRS.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -1366052.00
CRS.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -1366052.00
CRS.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -1366052.00
CRS.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -1366052.00
CRS.AX income_statement (annual, 2022-06-30) — Net Interest Income: -4312.00
CRS.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -4312.00
CRS.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -64004.00
CRS.AX balance_sheet (annual, 2022-06-30) — Net PPE: 11545281.00
CRS.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -281350.00
CRS.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 13276399.00
CRS.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -1321122.00
CRS.AX income_statement (annual, 2022-06-30) — Normalized Income: -1366052.00
CRS.AX income_statement (annual, 2022-06-30) — Operating Income: -1361465.00
CRS.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 102050409.00
CRS.AX balance_sheet (annual, 2022-06-30) — Other Current Assets: 52247.00
CRS.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 1885275.00
CRS.AX income_statement (annual, 2022-06-30) — Other Gand A: 357999.00
CRS.AX income_statement (annual, 2022-06-30) — Other Income Expense: -275.00
CRS.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: -275.00
CRS.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 274933.00
CRS.AX balance_sheet (annual, 2022-06-30) — Other Payable: 178757.00
CRS.AX balance_sheet (annual, 2022-06-30) — Other Properties: 11576110.00
CRS.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 50750.00
CRS.AX balance_sheet (annual, 2022-06-30) — Payables: 232716.00
CRS.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 232716.00
CRS.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -920068.00
CRS.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 11125.00
CRS.AX income_statement (annual, 2022-06-30) — Pretax Income: -1366052.00
CRS.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -281350.00
CRS.AX balance_sheet (annual, 2022-06-30) — Receivables: 50750.00
CRS.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 39291.00
CRS.AX cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -136125.00
CRS.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -5096805.00
CRS.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 689242.00
CRS.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 1047241.00
CRS.AX balance_sheet (annual, 2022-06-30) — Share Issued: 102050409.00
CRS.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 13276399.00
CRS.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 13276399.00
CRS.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
CRS.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
CRS.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
CRS.AX balance_sheet (annual, 2022-06-30) — Total Assets: 13618154.00
CRS.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 13276399.00
CRS.AX balance_sheet (annual, 2022-06-30) — Total Debt: 74740.00
CRS.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 13276399.00
CRS.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 341755.00
CRS.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 11545281.00
CRS.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 39269.00
CRS.AX balance_sheet (annual, 2022-06-30) — Working Capital: 1770387.00
CRS.AX income_statement (annual, 2023-06-30) — +Operating Expense: 1236719.00
CRS.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 83862.00
CRS.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -42031.00
CRS.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 119769209.00
CRS.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.01
CRS.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 1958751.00
CRS.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -1571713.00
CRS.AX cash_flow (annual, 2023-06-30) — Capital Expenditure Reported: -1472496.00
CRS.AX balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 38904.00
CRS.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 18162148.00
CRS.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 685771.00
CRS.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 685771.00
CRS.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 685771.00
CRS.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 1218383.00
CRS.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -1571713.00
CRS.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -919650.00
CRS.AX cash_flow (annual, 2023-06-30) — Changes In Cash: -1272980.00
CRS.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -925966.00
CRS.AX balance_sheet (annual, 2023-06-30) — Common Stock: 18162148.00
CRS.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 14312571.00
CRS.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 1337784.00
CRS.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -83565.00
CRS.AX balance_sheet (annual, 2023-06-30) — Current Assets: 789498.00
CRS.AX balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 38437.00
CRS.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 38437.00
CRS.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 280215.00
CRS.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 36192.00
CRS.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 39443.00
CRS.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 39443.00
CRS.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 39443.00
CRS.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 119769209.00
CRS.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.01
CRS.AX income_statement (annual, 2023-06-30) — EBIT: -1221486.00
CRS.AX income_statement (annual, 2023-06-30) — EBITDA: -1182043.00
CRS.AX cash_flow (annual, 2023-06-30) — End Cash Position: 685771.00
CRS.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 1218383.00
CRS.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -2491363.00
CRS.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 2427525.00
CRS.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 1093085.00
CRS.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 13845786.00
CRS.AX income_statement (annual, 2023-06-30) — Interest Expense: 5405.00
CRS.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 5405.00
CRS.AX income_statement (annual, 2023-06-30) — Interest Income: 11810.00
CRS.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 11810.00
CRS.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -5405.00
CRS.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 5405.00
CRS.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 11721.00
CRS.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 14312571.00
CRS.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -1571713.00
CRS.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 1337784.00
CRS.AX balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 467.00
CRS.AX balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 467.00
CRS.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 7056.00
CRS.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 1254219.00
CRS.AX income_statement (annual, 2023-06-30) — Net Income: -1226891.00
CRS.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -1226891.00
CRS.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -1226891.00
CRS.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -1226891.00
CRS.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -1226891.00
CRS.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -1226891.00
CRS.AX income_statement (annual, 2023-06-30) — Net Interest Income: 6405.00
CRS.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 6405.00
CRS.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -71672.00
CRS.AX balance_sheet (annual, 2023-06-30) — Net PPE: 13803755.00
CRS.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -99217.00
CRS.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 14312571.00
CRS.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -1182043.00
CRS.AX income_statement (annual, 2023-06-30) — Normalized Income: -1226891.00
CRS.AX income_statement (annual, 2023-06-30) — Operating Income: -1236719.00
CRS.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 144911084.00
CRS.AX balance_sheet (annual, 2023-06-30) — Other Current Assets: 52335.00
CRS.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 2427525.00
CRS.AX income_statement (annual, 2023-06-30) — Other Gand A: 461210.00
CRS.AX income_statement (annual, 2023-06-30) — Other Income Expense: 3423.00
CRS.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 3423.00
CRS.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 104191.00
CRS.AX balance_sheet (annual, 2023-06-30) — Other Payable: 121724.00
CRS.AX balance_sheet (annual, 2023-06-30) — Other Properties: 13838730.00
CRS.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 39337.00
CRS.AX balance_sheet (annual, 2023-06-30) — Payables: 205586.00
CRS.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 205586.00
CRS.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -925966.00
CRS.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 12055.00
CRS.AX income_statement (annual, 2023-06-30) — Pretax Income: -1226891.00
CRS.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -99217.00
CRS.AX balance_sheet (annual, 2023-06-30) — Receivables: 39337.00
CRS.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 39443.00
CRS.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -83565.00
CRS.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -6277102.00
CRS.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 631875.00
CRS.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 1093085.00
CRS.AX balance_sheet (annual, 2023-06-30) — Share Issued: 144911084.00
CRS.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 14312571.00
CRS.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 14312571.00
CRS.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
CRS.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
CRS.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
CRS.AX balance_sheet (annual, 2023-06-30) — Total Assets: 14593253.00
CRS.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 14312571.00
CRS.AX balance_sheet (annual, 2023-06-30) — Total Debt: 38904.00
CRS.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 14312571.00
CRS.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 280682.00
CRS.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 13803755.00
CRS.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 467.00
CRS.AX balance_sheet (annual, 2023-06-30) — Working Capital: 509283.00
CRS.AX income_statement (annual, 2024-06-30) — +Operating Expense: 1559592.00
CRS.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 93475.00
CRS.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -9694.00
CRS.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 181430412.00
CRS.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.01
CRS.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 685771.00
CRS.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -1877258.00
CRS.AX cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -773237.00
CRS.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 20632560.00
CRS.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 885583.00
CRS.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 885583.00